A New Mouse Model of Diffuse Midline Glioma to Test Targeted Immunotherapies
M. D. Seblani, M. Zannikou, J. Duffy, R. N. Levine, Q. Liu, C. M. Horbinski, O. Becher, I. Balyasnikova
This paper develops a new mouse model of diffuse midline glioma to evaluate IL13R2-targeted immunotherapies, showing tumors with histopathological features of pediatric gliomas.
bioRxiv · Oct 15, 2021Cancer Biology